Charcotrace Inj.

DRUG2 trials

Sponsors

Hanlim Pharm. Co., Ltd.

Conditions

Breast Diseases

Phase 2

To Evaluate the Efficacy and Safety of LuminoMark Injection in Patients With Nonpalpable Breast Lesions

CompletedNCT03743259

Hanlim Pharm. Co., Ltd.Breast Diseases

Start: 2018-05-29End: 2019-04-22Updated: 2019-06-06

Phase 3

To Evaluate the Efficacy and Safety of LuminoMark Injection in Patients With Nonpalpable Breast Lesions(Phase 3)

CompletedNCT04606329

Hanlim Pharm. Co., Ltd.Breast Diseases

Start: 2020-07-20End: 2021-01-28Updated: 2021-02-10

Related Papers

The efficacy and safety of indocyanine green-hyaluronic acid mixture (LuminoMark™) for localization in patients with non-palpable breast lesions: a multi-center open-label parallel phase-2 clinical trial

BMC Surgery2021-03-168 citations